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Abstract
Ubiquitination is a process that marks proteins for various cell-signaling pathways, namely protein degradation and 
other processes. Th ese pathways are essential in a wide array of cellular processes, including defense mechanisms 
against invading pathogens. Th e ubiquitination process is universally found in all eukaryotic organisms, including 
plants and animals, and thus plays a vital role in cellular homeostasis. Recently, more discoveries have been made on 
prokaryotic eff ector proteins that hijack the ubiquitination system even when they do not possess a ubiquitin system of 
their own. MavC, also known as lpg2147 (Gan, Nakayasu, Hollenbeck, & Luo, 2019; Puvar et al., 2020; Valleau et al., 
2018), has been found to be a ubiquitinating enzyme that ubiquitinates UbE2N by bypassing the usual E1, E2, E3 
ubiquitination pathway. MavC plays an important role in the infection of Legionella pneumophila, which is the culprit 
of Legionnaires’ disease. Th rough earlier molecular biology analysis, it has been discovered that a neighboring gene on 
the same locus as MavC encodes lpg2149, which has been characterized to inhibit MavC’s function. Given the novelty 
of this protein, this research project aims to achieve cloning, expression, and purifi cation of lpg2149 so that in its 
inhibitory complex lpg2149 can be captured by X-ray crystallography. An attempt was made to crystallize and obtain 
the structure of lpg2149 with MavC. With the optimization of lpg2149 production demonstrated in this project, a 
better understanding of L. pneumophila pathogenesis can be obtained, which would help in our understanding of 
regulating L. pneumophila infection.
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INTRODUCTION
Ubiquitination is a posttranslational modification that 
plays a role in many processes in eukaryotic cells, 
including protein degradation, protein trafficking, 
protein localization, and protein regulation. During 
ubiquitination, proteins are modified with the addition 
of a single ubiquitin or ubiquitin protein chains. The 
conformation and number of ubiquitin attached to the 
protein act as a code that determines that protein’s fate in 
the cell, one example being protein degradation. Three 
enzymes known as the E1, E2, and E3 enzymes take part 
in ubiquitination. E1s are ubiquitin-activating enzymes 
that catalyze the first step of ubiquitination, wherein 
adenosine triphosphate is used to generate an active 
ubiquitin that is primed for conjugation with E2. E2s are 
ubiquitin-conjugating enzymes that transfer ubiquitin to 
their partner E3s. Finally, E3s are ubiquitin-ligating 
enzymes that give specificity to the substrate proteins. 
More ubiquitin molecules can then be subsequently 
added to the initial ubiquitin, forming a polyubiquitin 
chain on the substrate protein. The conformation and 
number of ubiquitin attached to the substrate protein 
ultimately affect what happens to the protein. In humans, 
there are 2 E1s, 40 E2s, and more than 600 E3s 
(Komander & Rape, 2012). To replenish the cellular 
ubiquitin pool and to remove cellular response signals 
that arise from polyubiquitination, there are enzymes 
that can cleave the isopeptide bond formed between a 
specific protein and ubiquitin so the ubiquitin can be 
reused. These enzymes are deubiquitinating enzymes, 
and they essentially reverse ubiquitination (Clague, 
Urbé, & Komander, 2019).
Bacteria are prokaryotic organisms that do not possess the 
ubiquitination system of their own. However, many of 
these pathogens have evolved to secrete effector proteins 
that affect cellular pathways, like ubiquitination, in the 
host cells it invades. Effector proteins are biological 
molecules that act to hijack or inhibit host proteins, which 
in turn changes and regulates the function of that particu-
lar host protein. Legionella pneumophila is one of the 
bacteria that expresses effectors that target ubiquitination 
pathways in the host cell. Among the 330 effector proteins 
secreted by L. pneumophila is MavC, also known as 
lpg2147 (Puvar et al., 2020; Valleau et al., 2018). MavC 
aids in deactivating NF-κB, a major immune regulatory 
protein. When MavC is not present, the 
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ubiquitin-conjugating E2 enzyme UbE2N aids in activat-
ing a protein (NEMO) required to phosphorylate IκBα. In 
this phosphorylated state, IκBα dissociates from NF-κB, so 
NF-κB is activated (Sato, Yoshikawa, Yamashita, Yamagata, 
& Fukai, 2009). When MavC is active it adds ubiquitin to 
UbE2N, thus deactivating UbE2N, which leads to the 
downstream effect of no phosphorylation on IκBα (Gan et 
al., 2019; Valleau et al., 2018). IκBα remains attached to 
NF-κB, which prevents the immune response from 
kicking in, indicating that L. pneumophila inhibits NF-κB 
to suppress and bypass the host immune response.
Interestingly, MavC is regulated by another L. pneu-
mophila effector known as lpg2149. Lpg2149 acts as an 
inhibitor to MavC and also inhibits another protein, 
MvcA (lpg2148), which has a homologous structure to 
MavC. MvcA is a ubiquitin specific deamidase that 
targets ubiquitinated UbE2N (UbE2N-Ub), the reaction 
product of MavC (Valleau et al., 2018). These three 
effectors of L. pneumophila play an important role in the 
regulation of UbE2N during L. pneumophila infection. 
UbE2N plays a role in other cellular pathways outside of 
the NF-κB pathway, such as its importance in mitosis 
and p53 regulation. These other pathways related to 
UbE2N are necessary for the intracellular replication of 
L. pneumophila. Additionally, even though L. pneumoph-
ila needs to inactivate NF-κB to bypass the host immune 
response, prolonged deactivation of the NF-κB pathway 
negatively affects L. pneumophila intracellular replica-
tion. As a result, the bacteria need to be able to regulate 
ubiquitination of UbE2N in order to reproduce in the 
host as well as avoid the host immune response. Lpg2149 
is an interesting target for further study due to its 
important role in enzyme regulation of UbE2N manipu-
lators. Lpg2149 optimization is important for future 
studies that aim to better understand lpg2149 and L. 
pneumophila pathogenesis. In this project, a protocol to 
produce lpg2149 has been optimized so that crystalliza-
tion studies with its binding partners can be performed 
and for further studies of lpg2149 inhibition activity.
METHODS AND RESULTS
To produce the protein on a large scale, a recombinant 
protein production method was employed. First, the 
lpg2149 gene from L. pneumophila was cloned into an 
expression vector, followed by transformation into an 
Escherichia coli strain for protein expression. Protein 
expression was proceeded by affinity chromatography 
using the recombinantly introduced tag on the protein.
Site-Directed Mutagenesis and Cloning
Cloning a gene into a vector requires amplification by a 
process called polymerase chain reaction (PCR), which 
can be broken down into three steps: denaturation, 
annealing, and extension. Denaturation occurs at 95°C, a 
temperature that is high enough to break the hydrogen 
bonds between deoxyribonucleic acid (DNA) strands so 
they can separate. The temperature is then reduced to a 
value that is approximately 5°C lower than the theoreti-
cal melting point of the primers. This is the optimal 
temperature at which the primers anneal to the template 
DNA as the temperature is low enough so that the 
primers do not denature from the template DNA but 
high enough that they only bind to their specific comple-
mentary sequences. Generally, the temperature for 
annealing is around 45–65°C. The next step of PCR is 
extension, which occurs at 72°C. This is the optimal 
temperature at which the Taq polymerase enzyme 
functions. During extension, the polymerase enzyme 
extends the primer sequence by adding nucleotide bases 
to the 3′ end. PCR is conducted in a thermocycler that 
cycles through the different temperature settings of each 
step so that the three main steps of PCR can repeat. The 
thermocycler typically runs about 25–35 cycles, leading 
to the synthesis of millions of copies of the original DNA 
template (Figure 1a). Before conducting PCR, primers 
were designed to insert the lpg2149 gene into the 
expression vector pGEX-6p-1. These primers were 
designed with overhangs that insert into the multiple 
cloning site of the expression vector, hence forming the 
plasmid with our lpg2149 insert (Sarkar & Sommer, 
1990). Using a program called SnapGene, a primer was 
designed to specifically anneal to a particular DNA 
sequence. After the primers were designed and synthe-
sized, PCR was conducted to amplify the plasmid with 
the lpg2149 gene insert. Alternatively, PCR could also be 
used to perform site-directed mutagenesis to specifically 
mutate residues of interest for activity studies. With the 
primer, the codon of the desired mutation would be 
inserted in place of the wild-type amino acid codon, and 
the extension time would span the time it takes to 
elongate to the full length of the vector with insert.
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After PCR, DpnI enzyme was added to the reaction to cut 
up the parental template DNA that does not contain the 
desired gene. The parental DNA is methylated so the DpnI 
enzyme can digest parental DNA strands upon recognition 
of methylation patterns. This ensured that only the desired 
plasmid (with insert for cloning or with mutation for 
mutagenesis) was present. After DpnI digestion, the 
plasmids were transformed into DH5α bacteria. DH5α is a 
specific strain of E. coli that does not contain endA or recA 
genes. EndA encodes an enzyme, Endonuclease A, that 
digests DNA that is not a part of the bacteria. RecA encodes 
RecA, an enzyme involved in DNA recombination. The 
lack of these two enzymes allowed the plasmid to be 
reproduced without being cut up by the endonuclease A or 
recombined with the bacterial DNA by the RecA enzyme.
Transformation involves a process of incubating, heating, 
and cooling to enable the E. coli to take up the plasmid. 
First, the mutant plasmids were incubated with DH5α cells 
so that the plasmids could equally distribute around the E. 
coli (see Figure 1b). Once the plasmids had been incubated 
with the E. coli, the bacteria were subjected to heat shock 
by being placed in a water bath set at 42°C. The heat 
opened transient pores in the cell membrane of the E. coli, 
allowing the plasmids to enter the cell. The transformation 
mix was then cooled on ice for a few minutes to allow the 
pores to close before being incubated for an hour in 
Lysogeny broth (LB) media without antibiotics at 37°C. 
This period of outgrowth allowed the cells transformed 
with the plasmid to replicate. After the hour-long incuba-
tion, cells were plated on an LB agar plate supplemented 
with the antibiotic corresponding to the selectable antibi-
otic resistance gene in the plasmid (see Figure 1c), which 
allowed only the bacterial cells transformed with the 
plasmid to survive. The plate was then placed in a 37°C 
incubator overnight so the bacteria could grow and form 
colonies. The next day one of the colonies was transferred 
to a tube containing 10mL of LB media to set up an 
overnight culture (see Figure 1d). The 10 mL overnight 
culture was incubated at 37°C, and after about 16 hours the 
cells were pelleted for plasmid DNA extraction using a 
commercially available miniprep kit (see Figure 1e).
DNA extraction began by pelleting the bacteria and 
removing the LB media before resuspending it in the P1 
buffer, which contains 50 mM Tris-Cl at pH 8.0, 10 mM 
ethylenediaminetetraacetic acid and 100 µg/ml of ribonu-
clease A. Each of these components played an important 
FIGURE 1. The process of cloning a gene into an expression vector uses various techniques including (a) PCR, (b–d) DH5α 
bacteria transformation and cultures, (e) DNA plasmid extraction, and (f) DNA sequencing.
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role in DNA extraction. The Tris-Cl buffer helps to 
maintain a constant pH of around 8. Ethylenediamine-
tetra acetic acid chelates the metal ions, which decrease the 
activity of enzymes with metal ion cofactors such as 
deoxyribonuclease. As a result, this protected the plasmid 
DNA from being degraded by deoxyribonuclease. The 
ribonuclease A in the P1 buffer (Qiagen) helps to remove 
ribonucleic acid from the plasmid preparation by cutting 
up and degrading the bacterial ribonucleic acid. After the 
cells had been resuspended in 250 µL of P1 buffer, 250 µL 
of P2 buffer was added to lyse the cells, and the lysis 
reaction was incubated at room temperature for 5 min-
utes. P2 contains 1% sodium dodecyl sulfate (SDS) and 
200 mM NaOH. SDS is a detergent that punctures cell and 
nuclear membranes while also solubilizing the proteins 
and lipids that make up the membranes. The NaOH in the 
lysis buffer caused osmotic damage to the bacterial cell 
walls so that the plasmid DNA could leave the cell and 
come into the solution. After the lysis reaction, 350 µL of 
N3 buffer was added to neutralize the reaction. N3 buffer 
neutralizes the NaOH and SDS, allowing the cell debris, 
chromosomal DNA, and bacteria proteins to precipitate 
out. Additionally, N3 buffer has guanidine HCl to dena-
ture soluble proteins. After the reaction was neutralized, 
the sample was centrifuged for 10 minutes so that the cell 
debris, chromosomal DNA, and proteins were spun down 
into a pellet. The supernatant was then transferred to a 
spin column. It was centrifuged for 1 minute, and the 
flow-through was discarded. The column was then washed 
with 750 µL of PE buffer, which contains ethanol and 
removes excess salt from the column. The column was 
centrifuged for 1 minute. The flow-through was then 
discarded, and the column was centrifuged for an addi-
tional minute to remove any leftover wash buffer. The spin 
column was then placed into a clean 1.5 mL microcentri-
fuge tube, and 50 μl of EB buffer (10 mM Tris-Cl, pH 8.5) 
was added to elute the DNA. The solution sat on the 
membrane for 1 minute and then was centrifuged for 
1 minute. The spin column was then discarded, and the 
plasmid DNA was collected in the microcentrifuge tube. 
The extracted DNA could then be sequenced to ensure 
that it had the correct sequence (see Figure 1f).
Protein Expression
After the desired gene had been cloned into the vector of 
choice and the sequence was verified, the resultant 
plasmid needed to be introduced into BL21(DE3) 
bacteria so that the protein of interest could be recombi-
nantly expressed. BL21(DE3) is an optimized E. coli 
strain for protein expression. The process of BL21(DE3) 
transformation mirrored the DH5α transformation 
(Figures 2a and 2b).
FIGURE 2. Protein expression flowchart. The plasmid DNA is transformed into BL21(DE3) bacteria, and a bacterial culture 
is produced (a–d). IPTG is added to induce protein expression of the gene of interest (e). Then the cells are harvested by 
centrifuging them and removing the liquid LB media (f).
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After colonies were grown on the plate, one of the 
colonies was transferred into a tube containing 10mL of 
liquid LB media to set up an overnight culture (see 
Figure 2c). After the bacteria had been incubated in the 
LB media overnight, the 10 mL overnight culture was 
added to a 1L flask of LB media (see Figure 2d). This was 
inoculated for 2–3 hours, and then 350μL of 1M 
Isopropyl β-D-1-thiogalactopyranoside (IPTG, final 
concentration of 350μM) was added to the culture. IPTG 
was the reagent used to induce protein expression of the 
gene under the control of the lac operon. When IPTG 
was added, protein expression was induced because the 
lac repressor protein binds to the IPTG and dissociates 
from the lac operon. The incubation temperature was 
adjusted based on the protein being expressed. For this 
project, protein expression was induced at 18°C for 16 to 
18 hours (see Figure 2e). After protein expression, the 
cells were harvested by centrifuging for 6 minutes at 
3,000 rpm. Centrifuging the cultures caused the cells to 
spin down and collect as a pellet. The remaining liquid 
LB media was then removed so that all that remained 
were the pelleted cells (see Figure 2f).
Protein Purification
Once the bacterial cells were harvested by centrifugation, 
the proteins needed to be isolated from the cells. The 
harvested cells were resuspended in 1X PBS buffer. After 
the cells were resuspended, lysozyme was added. 
Lysozyme catalyzed the breaking down of the cell walls of 
bacteria (Figure 3a). After the lysozyme was added and 
incubated for 30 minutes, the cells were lysed using a 
French press. The French press applied high pressure to 
the cells, which caused the cells to break open (Figure 3b). 
After two passes through the French press, the solution 
was ultracentrifuged for an hour so that the cell debris, 
such as membranes, would spin to the bottom, allowing 
the supernatant, which contained the soluble proteins, to 
be collected (Figure 3c). The supernatant was then loaded 
into a protein purification column, and after allowing the 
proteins to equilibrate or bind to the beads, it was passed 
through the column. The protein purification column 
contained beads that bind to a specific tag that was 
incorporated into the protein of interest through the 
recombinant plasmid. The binding of the tag to the beads 
allowed all the other unwanted proteins to flow through 
while the protein of interest remained in the column 
(Figure 3d). There are different types of protein tags, and 
the process for purifying proteins differs slightly depend-
ing on which tag was incorporated in the protein of 
interest. This project used a pGEX-6p-1 plasmid, which 
incorporates a glutathione-S-transferase (GST) tag onto 
the N-terminus of lpg2149. GST tags bind to beads with 
chains of glutathione immobilized on the bead. The 
glutathione binds with the GST incorporated into the 
protein of interest with high selectivity and high affinity 
so that the protein of interest will remain in the column.
After the supernatant from the ultracentrifuge was 
equilibrated and passed through the column, the column 
was washed twice (each with a volume of 5 times the 
bead volume) with 1X PBS buffer to remove the proteins 
the bacteria had produced for normal cellular function 
(see Figure 3e). After the washes, an elution buffer was 
added to allow the protein of interest to flow through the 
column (see Figure 3f). For GST, free reduced glutathi-
one was used to elute, as the free glutathione would bind 
to the GST. This allowed the protein with GST that was 
bound to free glutathione to flow through the column. 
After elution, PreScission protease was then added to the 
eluate to cleave the GST tag off from the protein of 
interest. The solution was then placed in a dialysis bag.
Once the sample had been transferred to the dialysis 
bag, the dialysis bag was then placed in a buffer that 
contains 0.4 M KCl in 1X PBS. In addition, dithioth-
reitol could also be added to the dialysis buffer. 
Dithiothreitol is a reducing agent that prevents nonspe-
cific disulfide bonds from forming. As mentioned 
previously, during dialysis the GST tags that were 
previously attached to the protein of interest were 
proteolytically removed due to the action of the 
PreScission protease (Figure see 3g). However, the 
purpose of the dialysis was really to remove free 
glutathione from the GST tag so that subtraction could 
occur. Once dialysis had finished, the solution was run 
through the GST bead column again. The beads bind to 
the protein tag once more only if the free glutathione 
has been removed from the sample. Because the GST 
could again bind to the GST beads, the protein of 
interest would flow through, as it was no longer 
attached to the tag (see Figure 3h). The subtracted 
solution, which contained only the protein of interest, 
was then concentrated. Samples taken at various points 
during the process were run on gel electrophoresis to 
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analyze the affinity column purification (see Figure 3i). 
Size exclusion chromatography was then run to obtain 
a completely pure sample of the protein by further 
separating the desired protein and potential contami-
nants based on size. Size exclusion separates proteins by 
size, wherein smaller proteins elute at a longer retention 
time due to the path they have to take through the size 
exclusion beads (Figure 4). After the proteins of interest 
are obtained and purified, the proteins could be 
analyzed by activity assays or used for struc-
tural studies.
Crystallization and X-Ray Crystallography
A high concentration of the desired proteins was 
prepared following the previously described protocol 
and then added to different conditions from several 
commercially available crystal screening sets in hopes of 
growing a crystal. In each well of the set there are 
different condition buffers that lead to different vapor 
diffusion conditions, some more optimum for different 
protein crystals to grow in. The protein solution is then 
mixed with a small portion of the crystal screen buffer to 
FIGURE 3. Protein purification flowchart. Protein purification begins with cell lysis and the isolation of proteins from other 
cellular components (a–c). Affinity column purification is then conducted to isolate the protein of interest (red) from the 
undesired proteins (brown) (d–i). This occurs due to the tag (blue) binding affinity with the porous beads (black) and the 
elution buffer (green).
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form a drop on a cover slip. Th e cover slip is then 
inverted over the well and sealed. Th e concentration in 
the drop equilibrates with the concentration via vapor 
diff usion, hopefully allowing a crystal to form (Figure 
5a). When the proteins in the drop packs favorably, a 
crystal is formed. Th is crystal can then be looped and 
diff racted by X-ray diff raction (Figures 5b–d). In this 
process an X-ray beam is directed to the crystal, and by 
rotating the crystal, a complete sphere of data can be 
obtained. As the crystal is rotated, the beam will be 
diff racted at diff erent angles, thus forming a set of 
diff raction patterns. Th e set of diff raction patterns can be 
correlated to the distribution of electrons of individual 
atoms that make up the protein or protein complexes in 
the crystal. Th e diff raction pattern set is analyzed using 
computer soft ware, such as Phenix and CCP4, to give an 
outline of the electron density map (Figure 5e). Th e 
structure can then be solved by molecular replacement if 
a model is available or by stepwise amino acid fi tting to 
the density map if no model is present and atomic 
resolution data is available. Once the structure is solved, 
it can then be deposited to the Protein Data Bank, an 
online database that contains biological structures that 
have been solved to date (Figure 5f).
DISCUSSION AND FUTURE DIRECTION
As shown in Figure 4, a substantial amount of lpg2149 
was successfully produced following this optimized 
protocol. With this optimized protocol and lpg2149 
construct identifi ed, we wanted to see how lpg2149 
inhibits MavC and MvcA by obtaining a crystal structure. 
However, this was solved by another group before we 
obtained our structure (Wang et al., 2020). One of the 
future directions of this project is to study the mechanism 
of inhibition between lpg2149 and MavC. An inhibition 
assay, which involves the ubiquitination of UbE2N with 
the aid of MavC in the presence of diff ering concentra-
tions of lpg2149, can be used to observe the extent of 
wild-type lpg2149 inhibition on MavC (Figure 6a). As 
shown in the inhibition assay, with increasing amounts of 
lpg2149 a reduced amount of UbE2N-Ub is observed. 
Th ese inhibition assays can be used to analyze key 
FIGURE 4. Protein purification gel. The aff inity column purification gel lanes contain the protein ladder, the supernatant 
after French press lysis (load), the first flow-through, the wash, the eluate, the postdialysis, the subtracted sample, and 
the concentrated sample, respectively (a). Size exclusion is conducted, and a gel is run with fractions that appear only to 
contain the protein of interest (b).
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residues of lpg2149 by performing the assay with mutants 
of lpg2149. If specifi c residues of lpg2149 were mutated 
and then tested with the inhibition assay, the eff ects of 
these mutations in inhibiting MavC can be compared to 
those of wild-type lpg2149. If the ubiquitination of 
UbE2N is impaired, it can be deduced that the specifi c 
mutation of lpg2149 is of low importance, since lpg2149 
is still inhibiting MavC despite the mutation and vice 
versa. Additionally, the assay would test diff erent concen-
trations of lpg2149 with each mutation to see how the 
FIGURE 5. Crystallization and X-ray diff raction. Crystal screening is conducted to obtain a crystal (a–b). The crystal’s 
structure is analyzed and solved using X-ray diff raction and online programs (c–f).
FIGURE 6. Inhibition assays and residue sites. The results of an inhibition assay with an increasing concentration of 
lpg2149 are shown in the electrophoresis gel (a). Lpg2149 is shown with residue sites highlighted in violet that could be 
potentially mutated to test their importance in the binding of lpg2149 with MavC (b).
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concentration of mutated lpg2149 aff ected the reactions. 
Th e diff erent concentrations of lpg2149 were 0μM, 
0.1μM, 0.25μM, 0.5μM, 1μM, 2μM and 5μM. As a future 
direction, mutants that are presented on the MavC 
interface with lpg2149 (highlighted in violet, Figure 6b) 
can be the fi rst ones to be tested as residues that may play 
an important role in the binding of lpg2149 to MavC. 
Additionally, biolayer interferometry can be used to study 
the binding affi  nity by measuring the ratio of association 
to dissociation of lpg2149 with its binding partner. Th ese 
analysis methods studying the interactions of lpg2149 
with other L. pneumophila eff ectors would be benefi cial 
in improving our understanding of lpg2149 function and 
L. pneumophila pathogenesis.
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